-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Not long ago, Canaan Technology, an overall solution provider for domestic solid preparation smart factories, accepted research from Everbright Securities and other institutions.
In response to the issue of "the main reason for the rapid growth of fluid process equipment", the company responded that in recent years The rapid growth of the biopharmaceutical market has driven the demand for corresponding equipment
.
In fact, in recent years, domestic biopharmaceuticals, such as genetic engineering drugs, antibody drugs, and cell drugs, have continued to see new developments.
Investment in the capital market has also been increasing.
It can be said that the biopharmaceutical industry is in a golden age.
Under the circumstances, the demand for upstream fluid process equipment is also expected to usher in a new round of growth
.
Domestic biopharmaceuticals usher in the golden age, which will drive the growth of demand for fluid process equipment (picture source: Pharmaceutical Network) The biopharmaceutical market is developing rapidly.
Biopharmaceuticals are modern bioengineering based on genetic engineering, that is, using modern biotechnology to cut and chain DNA.
Connect, transform, and manufacture biological medicines
.
China’s biopharmaceutical industry started relatively late.
In recent years, with the rapid development of genetic engineering, antibody engineering, and cell engineering technologies, the continued increase in capital, and the encouragement and support of a series of favorable policies from the state to the local level, the domestic biopharmaceutical industry has developed rapidly , Showing cluster development, the entire market is expanding continuously and has great potential
.
Data show that the market size of China's biopharmaceutical industry has reached 350 billion yuan in 2019.
With the increase in residents' affordability, the growth of patient groups, and the expansion of medical insurance coverage, this market is expected to reach 400 billion yuan by 2020
.
According to the Frost & Sullivan report, it is estimated that by 2024, the size of China's biopharmaceutical market will exceed 100 billion U.
S.
dollars
.
The demand for fluid process equipment is expected to grow.
Fluid process equipment refers to equipment that uses fluid as a working medium to convert energy, including pumps and valves, pharmaceutical water equipment, pharmaceutical liquid dispensing systems, etc.
, all belong to the range of fluid process equipment and accessories, which can meet some pharmaceutical processes Requirements and ensure the continuity of production
.
In the biopharmaceutical field, fluid process equipment is a common key equipment.
With the rapid development of the biopharmaceutical industry, pharmaceutical companies have accelerated their capacity expansion.
Under this background, the demand for fluid process equipment is also expected to increase.
.
It is worth mentioning that the biopharmaceutical industry has high barriers to entry, not only requires high technological requirements, but also faces very strict supervision
.
In the context of the industry's increasing requirements for drug quality and safety, fluid process equipment is also facing the challenge of upgrading
.
It is understood that in recent years, with the fierce competition in the equipment industry and the upgrading of user needs, more and more biopharmaceutical fluid process suppliers have transformed from a single provider of equipment to biopharmaceutical fluid equipment solution providers to help users solve cost problems and Meet diversified needs
.
At the same time, in order to deepen the biopharmaceutical market, many equipment companies pay more attention to team building from the biopharmaceutical field, attracting talents with deep experience and knowledge of engineering construction, production equipment, and production of pharmaceutical technology to design, produce, and Install fluid equipment that meets CGMP and FDA standards, and provide a complete set of traceable verification supporting documents to meet the needs of high-end users
.
Conclusion In general, with the rapid development of the biopharmaceutical industry, the demand for related equipment is expected to increase
.
In addition, with the innovation and promotion of domestic equipment technology, gradually moving from low-end to mid-to-high end, the pace of substitution of domestic products will also accelerate, and more development opportunities will be ushered in high-end markets at home and abroad
.
For related equipment manufacturers, the present is both an opportunity and a challenge.
While seizing the development opportunity, it is necessary to increase R&D investment, continue to innovate, and create high-efficiency, low-cost, aseptic fluid process equipment to better serve biopharmaceuticals.
The development of the industry is escorted
.
In response to the issue of "the main reason for the rapid growth of fluid process equipment", the company responded that in recent years The rapid growth of the biopharmaceutical market has driven the demand for corresponding equipment
.
In fact, in recent years, domestic biopharmaceuticals, such as genetic engineering drugs, antibody drugs, and cell drugs, have continued to see new developments.
Investment in the capital market has also been increasing.
It can be said that the biopharmaceutical industry is in a golden age.
Under the circumstances, the demand for upstream fluid process equipment is also expected to usher in a new round of growth
.
Domestic biopharmaceuticals usher in the golden age, which will drive the growth of demand for fluid process equipment (picture source: Pharmaceutical Network) The biopharmaceutical market is developing rapidly.
Biopharmaceuticals are modern bioengineering based on genetic engineering, that is, using modern biotechnology to cut and chain DNA.
Connect, transform, and manufacture biological medicines
.
China’s biopharmaceutical industry started relatively late.
In recent years, with the rapid development of genetic engineering, antibody engineering, and cell engineering technologies, the continued increase in capital, and the encouragement and support of a series of favorable policies from the state to the local level, the domestic biopharmaceutical industry has developed rapidly , Showing cluster development, the entire market is expanding continuously and has great potential
.
Data show that the market size of China's biopharmaceutical industry has reached 350 billion yuan in 2019.
With the increase in residents' affordability, the growth of patient groups, and the expansion of medical insurance coverage, this market is expected to reach 400 billion yuan by 2020
.
According to the Frost & Sullivan report, it is estimated that by 2024, the size of China's biopharmaceutical market will exceed 100 billion U.
S.
dollars
.
The demand for fluid process equipment is expected to grow.
Fluid process equipment refers to equipment that uses fluid as a working medium to convert energy, including pumps and valves, pharmaceutical water equipment, pharmaceutical liquid dispensing systems, etc.
, all belong to the range of fluid process equipment and accessories, which can meet some pharmaceutical processes Requirements and ensure the continuity of production
.
In the biopharmaceutical field, fluid process equipment is a common key equipment.
With the rapid development of the biopharmaceutical industry, pharmaceutical companies have accelerated their capacity expansion.
Under this background, the demand for fluid process equipment is also expected to increase.
.
It is worth mentioning that the biopharmaceutical industry has high barriers to entry, not only requires high technological requirements, but also faces very strict supervision
.
In the context of the industry's increasing requirements for drug quality and safety, fluid process equipment is also facing the challenge of upgrading
.
It is understood that in recent years, with the fierce competition in the equipment industry and the upgrading of user needs, more and more biopharmaceutical fluid process suppliers have transformed from a single provider of equipment to biopharmaceutical fluid equipment solution providers to help users solve cost problems and Meet diversified needs
.
At the same time, in order to deepen the biopharmaceutical market, many equipment companies pay more attention to team building from the biopharmaceutical field, attracting talents with deep experience and knowledge of engineering construction, production equipment, and production of pharmaceutical technology to design, produce, and Install fluid equipment that meets CGMP and FDA standards, and provide a complete set of traceable verification supporting documents to meet the needs of high-end users
.
Conclusion In general, with the rapid development of the biopharmaceutical industry, the demand for related equipment is expected to increase
.
In addition, with the innovation and promotion of domestic equipment technology, gradually moving from low-end to mid-to-high end, the pace of substitution of domestic products will also accelerate, and more development opportunities will be ushered in high-end markets at home and abroad
.
For related equipment manufacturers, the present is both an opportunity and a challenge.
While seizing the development opportunity, it is necessary to increase R&D investment, continue to innovate, and create high-efficiency, low-cost, aseptic fluid process equipment to better serve biopharmaceuticals.
The development of the industry is escorted
.
